Pharma

EU Agency Issues Guideline on Biosimilar MS Drugs

Topics • Technology

Counterfeit Pharmaceuticals

Pharma Asks The Money Question Earlier For New Drugs

AstraZeneca, Novartis and Sanofi Douse Hopes For New Drugs

Healthcare Reform in the U.S.: What Supreme Court Ruling Could Mean

All-round Pharma Service Providers See Potential in Asia, Elsewhere

Hikma Pharma, Vifor Pharma Enter into Licensing, Distribution Deal

Bristol-Myers Sees Q2 Profit Drop

Sanofi-Aventis Q2 Profit Slips

Pharmaceutical Product Development Q2 Profit Rises

GlaxoSmithKline Swings to Profit In Q2

Bristol-Myers to Acquire Amira Pharma For $325 Million

Abbott Laboratories Q2 Profit Surges 50%

Merck Inks New Non-Exclusive Agreement With Roche

Forest Labs Q1 Profit Tops Views

Johnson & Johnson Q2 Profit Down

Amgen Settles G-CSF Patent Litigation with Teva

Bayer Loses European Patent For Yasmin

Slovenia's Krka Jan-June Sales Up 6% Year-On-Year

Merck Loses Bid To Recoup $473 Million In U.S.

Roche to Provide Tests for Merck Cancer Drugs

Topics • Technology

The World Of Biosimilars

Takeda To Reveal $12 Billion Purchase Of Nycomed

Teva CEO Shlomo Yanai Says Always Looking for More Acquisitions

Teva to buy 57% of Taiyo for $460 Million

Takeda Denies Nycomed Bid

Topics • Technology

Flexibility in Bioprocessing

Topics • Technology

Porsche Consulting on Lessons from the Auto Industry

U.S. Top Court Questions State Drug Data Limits

Genome Study Brings Blood Cancer Into Sharp Focus

Russia Set for More Inward Pharma Investment

Karl-Ludwig Kley: Merck KGaA May Sell Non-Prescription Drugs Business

Lonza Expects Solid Growth in 2011, 2010 Net Up 79%

Topics • Technology

The Pharmaceutical Industry On The Move

Novartis Buys Cancer Diagnosis Specialist Genoptix For $470 Million

38 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Saltigo GmbH

Veeva Systems

Clariant International Ltd

Evonik Industries AG

PA Consulting Group

CMS Advisors GmbH & Co. KG

AGC Biologics

Northway Biotech

Symbiosis Pharmaceutical Services

GETEC Group

Camelot Management Consultants AG

Lonza Capsugel

AmbioPharm, Inc.

WeylChem International GmbH

Cambrex Corporation

Lilly Deutschland GmbH

gempex GmbH – THE GMP-EXPERT

Farmindustria

LISA Life Science Austria

Ecocool GmbH

Thomson Reuters

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

Adragos Pharma

CHEManager International c/o Wiley-VCH GmbH

AstraZeneca

Helsinn Chemicals SA

Arthur D. Little

Pfizer, Inc.

Eli Lilly and Company

WuXi AppTec

Packaging Coordinators, Inc.

Catalent Inc.

Datamonitor Group

ARC Advisory Group GmbH & Co KG

IMCD Group B.V.

Oxford Instruments